Login / Signup

Novel and emerging drugs for the treatment of Crohn's disease: a review of phase II and III trials.

Panu WetwittayakhlangTalat BessissowPeter Laszlo Lakatos
Published in: Expert opinion on emerging drugs (2024)
The armamentarium of CD therapeutic agents is constantly expanding. We analyze pivotal findings from phase 2 and phase 3 CD treatment trials. We also underscore the existing gaps in therapy and the paramount role of ongoing research and innovation in CD management.
Keyphrases
  • phase ii
  • clinical trial
  • open label
  • randomized controlled trial
  • stem cells
  • nk cells
  • combination therapy
  • replacement therapy
  • cell therapy
  • double blind
  • smoking cessation
  • chemotherapy induced